Tuberculosis Research Funding Trends 2005 — 2023
This new report released by Treatment Action Group (TAG) and Stop TB Partnership found that cumulative funding for tuberculosis (TB) research and development (R&D) in 2023 reached only 24% of the annual $5 billion funding target agreed by countries at the United Nations High-Level Meeting (HLM) on TB in September 2023. Significant acceleration of investment — bolstered by broader democratic support from more diversified sources of funding — is necessary to develop and scale up the tools necessary to end TB as a public health crisis by 2030. The report was launched during the 38th Stop TB Partnership Board Meeting in Abuja, Nigeria.
TB remains the world’s top infectious disease killer, with 1.25 million people dying in 2023 and 10.8 million getting sick. It is preventable and curable, but eliminating it globally will require better vaccines, diagnostics, and treatments. Chronic underfunding remains a major barrier to delivering on the promise of innovations currently in the research pipeline.
Read the full press release here
Download
Link
